According to GlobalData, the worldwide thrombectomy device market was worth $2.96 billion in 2024 and is set to register a ...

Stryker has completed its $4.9 billion acquisition of Inari Medical, a company specializing in venous thromboembolism ...

Inari’s expertise combined with Stryker’s existing distribution and logistics network could boost volume and procedure ...

Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) has been given a consensus rating of “Hold” by the fourteen research firms that are currently covering the company, MarketBeat reports. Twelve ...

Teamwork: A Multidisciplinary Approach to Early Lung Cancer: Personalized Care A nurse practitioner with NYU's pulmonary intervention team chronicles the NSCLC patient experience from diagnosis to ...

Background The overall safety and efficacy of mechanical thrombectomy (MT) for acute ischemic stroke (AIS) in frail patients is not well delineated. This systematic review aims to summarize and ...

Slightly more than half of all patients experiencing VTE presented with deep-vein thrombosis, and the rest presented with pulmonary embolism. These findings reinforce previously published data ...

Venous Thromboembolism Treatment Market The venous Thromboembolism Treatment Market growth is driven by rising VTE prevalence, anticoagulan ...

State of New Jersey Common Pension Fund D lessened its holdings in Inari Medical, Inc. (NASDAQ:NARI – Free Report) by 10.6% ...

1920 E. Hallandale Beach Blvd., Suite 905, Hallandale, FL 33009 ...